ANDREW CHAN
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
PETER BLOCH, PETER BLOCH,, ANDREW CHAN,, DAVID CRAMB, DAVID CRAMB,, JEFFREY DAWLEY, PAUL DUFFY, EVAN GAPPELBERG, WILLIAM GILDEA, ORI INBAR, NIDHI KUMRA, NIDHI KUMRA,, KASHIF MALIK, DAVID MILES, ANTHONY PIZZONIA, ANTHONY PIZZONIZ,, REUBEN TOZMAN, BELINDA TYLDESLEY, BELINDA TYLDESLEY,, ANUM WAQAS, ANUM WAQAS,, EUGEN WINSCHEL
EXECUTIVE OFFICER
PETER BLOCH, PETER BLOCH,, ANDREW CHAN,, DAVID CRAMB, DAVID CRAMB,, JEFFREY DAWLEY, PAUL DUFFY, EVAN GAPPELBERG, WILLIAM GILDEA, ORI INBAR, NIDHI KUMRA, NIDHI KUMRA,, KASHIF MALIK, DAVID MILES, ANTHONY PIZZONIA, ANTHONY PIZZONIZ,, REUBEN TOZMAN, BELINDA TYLDESLEY, BELINDA TYLDESLEY,, ANUM WAQAS, ANUM WAQAS,, EUGEN WINSCHEL
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER
SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
DECLINE TO DISCLOSE
Equity
2023-11-29
D
OTHER
SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
DECLINE TO DISCLOSE
Equity
2022-01-20
D
OTHER
SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
DECLINE TO DISCLOSE
Equity
2021-10-31
D
OTHER
SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
$5,000,001 - $25,000,000
Equity
2021-08-26
D
OTHER
SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
$5,000,001 - $25,000,000
Equity
2021-06-25
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2018-01-30

